Advancements in Regenerative Therapies for Orthopedics: A Comprehensive Review of Platelet-Rich Plasma, Mesenchymal Stem Cells, Peptide Therapies, and Biomimetic Applications
Open accessThe DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index; 50 of the 77 sources its claims cite were checked for support.
Abstract
Background/Objectives: Regenerative therapies have gained interest in orthopedic applications for their potential to enhance tissue regeneration, functional recovery, and pain modification. This review evaluates the clinical efficacy of platelet-rich plasma (PRP), mesenchymal stem cells (MSCs), peptide-based treatments, and biomimetic materials in orthopedic care, with a focus on pain reduction and functional outcomes. Methods: A structured literature search in PubMed (January 2009–January 2025) identified 160 studies. After applying inclusion criteria prioritizing randomized controlled trials (RCTs) and clinical trials, 59 studies were included: 20 on PRP, 20 on MSCs, 10 on peptide therapies, and 7 on biomimetics. Data extraction focused on pain reduction and functional recovery, with risk of bias assessed using the Cochrane Risk of Bias (RoB) tool and ROBINS-I tool. A random-effects meta-regression analysis was conducted to evaluate the impact of therapy type, sample size, and risk of bias on reported pain reduction outcomes. Results: Meta-regression analysis identified MSC therapy as the most effective intervention for pain reduction (β = 8.45, p < 0.05), with PRP and peptide-based therapies showing moderate improvements, and biomimetic therapies demonstrating the lowest effect. PRP provided short-term pain relief, particularly in acute injuries and tendon repair, though inconsistencies in preparation methods limited success in chronic conditions. MSC therapies demonstrated cartilage regeneration and early osteoarthritis improvement, but high costs and ethical concerns remain barriers to widespread adoption. Peptide-based therapies and biomimetic materials, including engineered scaffolds and autologous protein solutions, showed promise for infection control and wound healing, though further research is needed to optimize dosing, delivery methods, and long-term safety. Conclusions: Regenerative therapies offer significant potential in orthopedic care, with MSC therapies demonstrating the most reliable regenerative effects, PRP providing short-term symptomatic relief, and peptide-based and biomimetic treatments emerging as promising adjuncts. However, standardized protocols and large-scale clinical trials are needed to establish long-term efficacy and improve clinical translation for broader adoption.
Overview
CoChat Summary
TL;DR
This review compares clinical evidence for PRP, mesenchymal stem cells (MSCs), peptide therapies, and biomimetic materials in orthopedic care, focusing on pain reduction and functional recovery. Across 59 included studies, MSCs showed the strongest pain-reduction signal, while PRP tended to provide short-term relief and peptide/biomimetic approaches remained promising but less established.
Key findings
- The PubMed search (January 2009–January 2025) identified 160 studies, and 59 studies met inclusion criteria: 20 PRP, 20 MSC, 10 peptide, and 7 biomimetic studies.
- Mean reported pain reduction was highest for MSC therapy (45.05 ± 3.85%), followed by PRP (41.00 ± 6.36%), biomimetic therapies (37.43 ± 2.82%), and peptide therapies (35.50 ± 3.03%).
- Welch’s ANOVA showed a significant difference in pain reduction across therapy types (F(3, 43) = 13.31, p < 0.001). Games–Howell tests found stem cell therapy had significantly greater pain reduction than peptides, PRP, and biomimetics (all p < 0.001).
- Meta-regression found therapy type significantly influenced pain reduction (QM(df = 3) = 14.15, p < 0.05); sample size and risk of bias were not significant predictors, and residual heterogeneity remained high (I² = 81.13%).
Methods
- This was a comprehensive review of clinical orthopedic studies on PRP, MSCs, peptide therapies, and biomimetic materials, using a PRISMA-guided PubMed search from January 2009 to January 2025.
- Inclusion prioritized clinical trials and randomized controlled trials; studies had to report orthopedic outcomes such as pain reduction, functional recovery, infection rates, healing time, or quality-of-life measures. Preclinical, non-English, or otherwise ineligible studies were excluded.
- Risk of bias was assessed with the Cochrane RoB tool and ROBINS-I. The authors then conducted a random-effects meta-regression (REML) plus one-way ANOVA/Welch’s ANOVA and Games–Howell post hoc tests in R 4.4.2.
Limitations
- The paper states that 10 studies were omitted from the pain-reduction analysis because that outcome was missing or unreported; it notes this was most common in PRP studies.
- The review reports substantial residual heterogeneity (I² = 81.13%), meaning important study-level factors likely remained unmeasured.
- Many included studies were single-center with small sample sizes, limiting generalizability; the paper also notes heterogeneity in PRP preparation, MSC sourcing, and peptide dosing, and limited long-term follow-up.
- Evident from the text: the quantitative synthesis focused on pain reduction, so conclusions about broader outcomes like function, durability, or safety are less directly supported by the pooled analysis.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
33 Valid · 9 Not valid · 16 Not checked · 58 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“PRP also appears to have limited benefit in certain conditions, such as Achilles tendinopathy and knee osteoarthritis, where trials have reported no significant improvement over placebo [109].”
§ Advancements in Regenerative Therapies for Orthopedics: A Comprehensive Review of Platelet-Rich Plasma, Mesenchymal Stem Cells, Peptide Therapies, and Biomimetic Applications > 4. Discussion > 4.1. Platelet-Rich Plasma (PRP)
What the sources say
- Disputedcites [109] Pojala, 2024, The potential of intra-articular therapies in managing knee osteoarthritis: A systematic review, Clin. Pract. sourceExperimental — accuracy not yet measured
The Results (§3.3; page unavailable) describe substantial improvements in pain and function with PRP for knee osteoarthritis, and the Discussion (§4.2; page unavailable) reports benefits over hyaluronic acid. This runs contrary to the claim of limited benefit for knee osteoarthritis, although the review does not establish the specific placebo comparison. The retrieved passages do not address Achilles tendinopathy. (LLM, conf=0.84)
Checked by a reasoning model — may be wrong.
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Traditionally, treatments such as surgical repair, physical therapy, and pharmaceutical interventions have been employed to address these conditions, but they frequently result in variable outcomes and inconsistent recovery periods [1].”
§ Advancements in Regenerative Therapies for Orthopedics: A Comprehensive Review of Platelet-Rich Plasma, Mesenchymal Stem Cells, Peptide Therapies, and Biomimetic Applications > 1. Introduction
What the sources say
- Could not verifycites [1] Choi, 2022, Enhanced Recovery After Surgery for Major Orthopedic Surgery: A Narrative Review, Knee Surg. Relat. Res. sourceExperimental — accuracy not yet measured
The Outcomes of ERAS section (LOS; page unavailable) reports shorter hospital stays with ERAS than with control or non-ERAS care. The Multimodal and standardized care system section (page unavailable) recommends standardized pathways, but neither passage says that surgical repair, physical therapy, and pharmaceutical interventions frequently produce variable outcomes or inconsistent recovery periods. Searches for traditional treatments and recovery variability found no passage establishing that claim. (LLM, conf=0.73)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Peptide-based therapies, which encompass antimicrobial peptides and growth factors, are particularly appealing for their dual ability to combat infection and promote healing [23,24].”
§ Advancements in Regenerative Therapies for Orthopedics: A Comprehensive Review of Platelet-Rich Plasma, Mesenchymal Stem Cells, Peptide Therapies, and Biomimetic Applications > 1. Introduction
What the sources say
- Partly supportedcites [23] Zarghami, 2021, Prevention of biofilm formation on orthopedic implants by melittin thin layer on chitosan/bioactive glass/vancomycin coatings, J. Mater. Sci. Mater. Med. sourceExperimental — accuracy not yet measured
The Abstract reports that melittin, an antimicrobial peptide, increased MC3T3 cell proliferation and that coatings combining melittin with vancomycin eliminated MRSA and VRSA bacteria. This supports infection control and a healing-related cellular effect in this specific implant coating, but the paper does not establish that peptide-based therapies generally, including growth factors, both combat infection and promote healing. (LLM, conf=0.86)
- Partly supportedcites [24] Park, 2011, The role of antimicrobial peptides in preventing multidrug-resistant bacterial infections and biofilm formation, Int. J. Mol. Sci. sourceExperimental — accuracy not yet measured
The Introduction describes antimicrobial peptides as potential alternatives to antibiotics, and the Conclusions say they may combat multidrug-resistant and biofilm-forming infections. The passages do not establish that these peptides promote healing or discuss growth factors as part of a dual infection-and-healing therapy. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Similarly, MSC-based therapies, particularly those utilizing MSCs derived from bone marrow, adipose tissue, or umbilical cord blood, offer substantial regenerative potential due to their ability to differentiate into various tissue types and modulate immune responses [17,18].”
§ Advancements in Regenerative Therapies for Orthopedics: A Comprehensive Review of Platelet-Rich Plasma, Mesenchymal Stem Cells, Peptide Therapies, and Biomimetic Applications > 1. Introduction
What the sources say
- Not checked — no full text of the sourcecites [17] Dominici, 2006, Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement, Cytotherapy source
- Partly supportedcites [18] Zampogna, 2024, Safety and efficacy of autologous adipose-derived stem cells for knee osteoarthritis in the elderly population: A systematic review, J. Clin. Orthop. Trauma. sourceExperimental — accuracy not yet measured
The Introduction (page not supplied) says MSCs can differentiate into chondrocytes and describes cytokines and growth factors that may promote cartilage repair. This supports regenerative potential, particularly for adipose-derived MSCs, but the paper does not establish immune-response modulation or the same potential for umbilical-cord-blood-derived MSCs. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Additionally, growth factor-derived peptides have been explored as adjunct therapies to PRP, demonstrating enhanced wound healing and tendon regeneration [101,102].”
§ Advancements in Regenerative Therapies for Orthopedics: A Comprehensive Review of Platelet-Rich Plasma, Mesenchymal Stem Cells, Peptide Therapies, and Biomimetic Applications > 3. Results > 3.3. Peptide Therapies
What the sources say
- Not checked — no full text of the sourcecites [101] Pugliese, 2017, Peptidic Biomaterials: From Self-Assembling to Regenerative Medicine, Trends Biotechnol. source
- Could not verifycites [102] Hao, Z., Chen, R., Chai, C., Wang, Y., Chen, T., Li, H., Hu, Y., Feng, Q., and Li, J. (2022). Antimicrobial Peptides for Bone Tissue Engineering: Diversity, Effects, and Applications. Front. Bioeng. Biotechnol., 10. sourceExperimental — accuracy not yet measured
The Introduction discusses antimicrobial peptides in wound repair, and §3.4 discusses their regenerative effects in bone tissue engineering. Neither passage addresses growth factor-derived peptides used alongside PRP or an effect on tendon regeneration. Searches for PRP, tendon, and growth factor-derived peptides found no passage establishing the attributed claim. (LLM, conf=0.76)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
62 more claims · 13 with their cited sources checked
Create a free account to see all 116 claims and to verify the 11 references still open.
- It may state two separate claims as one. 47
- Probably not a substantial claim. 3
Statistics recomputed
Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.
- ConsistentF(3, 43) = 3.64reported p < .05 · recomputed p = .020
“F(3, 43) = 3.64, p < .05”
- ConsistentF(3, 43) = 13.31reported p < .001 · recomputed p < .001
“F(3, 43) = 13.31, p < .001”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Advancements in Regenerative Therapies for Orthopedics: A Comprehensive Review of Platelet-Rich Plasma, Mesenchymal Stem Cells, Peptide Therapies, and Biomimetic Applications > Abstract
“After applying inclusion criteria prioritizing randomized controlled trials (RCTs) and clinical trials, 59 studies were included: 20 on PRP, 20 on MSCs, 10 on peptide therapies, and 7 on biomimetics.”
§ Advancements in Regenerative Therapies for Orthopedics: A Comprehensive Review of Platelet-Rich Plasma, Mesenchymal Stem Cells, Peptide Therapies, and Biomimetic Applications > 2. Methods > 2.4. Statistical Analysis
“The final dataset included 20 PRP studies, 20 stem cell studies, 10 peptide studies, and 7 biomimetic studies.”
Citations
Cites
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Sterne, J. A., Hernán, M. A., Reeves, B. C., Savović, J., Berkman, N. D., Viswanathan, M., Henry, D., Altman, D. G., Ansari, M. T., Boutron, I., et al. (2016) · BMJ · doi:10.1136/bmj.i4919 · Cited by 20,329 · cited 1×
“The risk of bias assessment was conducted using the Cochrane Risk of Bias tool for randomized controlled trials and the Risk of Bias in Non-randomized Studies of Interventions (ROBINS-I) tool for non-randomized and observational studies [35,36].”
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., Deans, R. J., Keating, A., Prockop, D. J., & Horwitz, E. M. (2006) · Cytotherapy · doi:10.1080/14653240600855905 · Cited by 17,766 · cited 1×
“Similarly, MSC-based therapies, particularly those utilizing MSCs derived from bone marrow, adipose tissue, or umbilical cord blood, offer substantial regenerative potential due to their ability to differentiate into various tissue types and modulate immune responses [17,18].”
Antimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457 · cited 2×
“Orthopedic surgery often involves managing complex musculoskeletal injuries and degenerative conditions that pose challenges in achieving complete functional recovery. tissue regeneration [25,26].”
Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies
Zuk, P. A., Zhu, M., Mizuno, H., Huang, J., Futrell, J. W., Katz, A. J., Benhaim, P., Lorenz, H. P., & Hedrick, M. H. (2001) · Tissue Engineering · doi:10.1089/107632701300062859 · Cited by 7,956
Biomaterials & scaffolds for tissue engineering
O'Brien, F. J. (2011) · Materials Today · doi:10.1016/s1369-7021(11)70058-x · Cited by 3,437 · cited 2×
“2 of 23 Biomimetic materials, including engineered scaffolds and autologous protein solutions, represent an emerging class of regenerative therapies aimed at mimicking natural tissue environments to facilitate healing and integration [28,29].”
Therapeutic Peptides: Current Applications and Future Directions
Wang, L., Wang, N., Zhang, W., Cheng, X., Yan, Z., Shao, G., Wang, X., Wang, R., & Fu, C. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00904-4 · Cited by 2,131 · cited 1×
“Peptides integrated into bioactive scaffolds show potential for infection con-trol and tissue regeneration, yet clinical translation remains limited [127,128].”
Mesenchymal stem cell perspective: cell biology to clinical progress
Pittenger, M. F., Discher, D. E., Péault, B. M., Phinney, D. G., Hare, J. M., & Caplan, A. I. (2019) · npj Regenerative Medicine · doi:10.1038/s41536-019-0083-6 · Cited by 2,008 · cited 1×
“Clinical applications of MSCs in cartilage repair, early-stage osteoarthritis, and fracture healing have shown encouraging results, especially in early degenerative conditions [19–21].”
Platelet-Rich Plasma (PRP): What Is PRP and What Is Not PRP?
Marx, R. E. (2001) · Implant Dentistry · doi:10.1097/00008505-200110000-00002 · Cited by 1,704
Bias and Efficiency of Meta-Analytic Variance Estimators in the Random-Effects Model
Viechtbauer, W. (2005) · Journal of Educational and Behavioral Statistics · doi:10.3102/10769986030003261 · Cited by 1,699 · cited 1×
“To evaluate differences in pain reduction across therapy types while accounting for between-study heterogeneity, a random-effects meta-regression analysis was conducted using the restricted maximum likelihood (REML) method [37,38].”
Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020
(2020) · doi:10.3390/ijms21207794 · Cited by 1,039
Chung, C., & Burdick, J. A. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.027 · Cited by 760 · cited 1×
“Engineered scaffolds are especially valuable in joint repair, as they offer structural support while promoting cellular proliferation and matrix deposition [30,31].”
Challenges and advances in clinical applications of mesenchymal stromal cells
Zhou, T., Yuan, Z., Weng, J., Pei, D., Du, X., He, C., & Lai, P. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01037-x · Cited by 712 · cited 1×
“However, logistical, and ethical challenges, including high costs, regulatory concerns, and MSC sourcing variability such as bone marrow-derived vs. adipose-derived MSCs, limit widespread clinical adoption [99].”
Lee, W.-S., Kim, H. J., Kim, K.-I., Kim, G. B., & Jin, W. (2019) · Stem Cells Translational Medicine · doi:10.1002/sctm.18-0122 · Cited by 497
Park, Y.-B., Ha, C.-W., Lee, C.-H., Yoon, Y. C., & Park, Y.-G. (2017) · Stem Cells Translational Medicine · doi:10.5966/sctm.2016-0157 · Cited by 446
Matas, J., Orrego, M., Amenabar, D., Infante, C., Tapia-Limonchi, R., Cadiz, M. I., Alcayaga-Miranda, F., González, P. L., Muse, E., Khoury, M., et al. (2019) · Stem Cells Translational Medicine · doi:10.1002/sctm.18-0053 · Cited by 413
Role of mesenchymal stem cells in bone regeneration and fracture repair: a review
Wang, X., Wang, Y., Gou, W., Lu, Q., Peng, J., & Lu, S. (2013) · International Orthopaedics · doi:10.1007/s00264-013-2059-2 · Cited by 357 · cited 1×
“Clinical applications of MSCs in cartilage repair, early-stage osteoarthritis, and fracture healing have shown encouraging results, especially in early degenerative conditions [19–21].”
Liu, S., Yu, J.-M., Gan, Y.-C., Qiu, X.-Z., Gao, Z.-C., Wang, H., Chen, S.-X., Xiong, Y., Liu, G.-H., Lin, S.-E., et al. (2023) · Military Medical Research · doi:10.1186/s40779-023-00448-w · Cited by 357 · cited 1×
“Biomimetic materials, including engineered scaffolds and autologous protein solutions, aim to mimic native tissue environments but require further refinement in delivery methods and long-term safety [129,130].”
Park, S.-C., Park, Y., & Hahm, K.-S. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12095971 · Cited by 327 · cited 1×
“Peptide-based therapies, which encompass antimicrobial peptides and growth factors, are particularly appealing for their dual ability to combat infection and promote healing [23,24].”
Chen, X., Jones, I. A., Park, C., & Vangsness, C. T. (2018) · The American Journal of Sports Medicine · doi:10.1177/0363546517743746 · Cited by 294 · cited 1×
“However, PRP’s therapeutic efficacy varies, largely due to inconsistent preparation methods and differing platelet concentrations, which can significantly influence treatment outcomes [13,14].”
Mesenchymal stem cell-derived exosomes: a new therapeutic approach to osteoarthritis?
Mianehsaz, E., Mirzaei, H. R., Mahjoubin-Tehran, M., Rezaee, A., Sahebnasagh, R., Pourhanifeh, M. H., Mirzaei, H., & Hamblin, M. R. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1445-0 · Cited by 274 · cited 1×
“While some trials have demonstrated substantial cartilage repair and functional improvement, others have reported minimal to no long-term benefit, particularly in advanced osteoarthritis patients [112].”
Ethical issues in stem cell research and therapy
King, N. M., & Perrin, J. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt474 · Cited by 267 · cited 1×
“The immunomodulatory properties of MSCs make them adaptable across diverse injury types, yet challenges persist regarding their accessibility and ethical implications, which restrict MSC therapies from achieving broader clinical adoption [22].”
Biomaterials for Tissue Engineering
Lee, E. J., Kasper, F. K., & Mikos, A. G. (2014) · Annals of Biomedical Engineering · doi:10.1007/s10439-013-0859-6 · Cited by 252 · cited 2×
“2 of 23 Biomimetic materials, including engineered scaffolds and autologous protein solutions, represent an emerging class of regenerative therapies aimed at mimicking natural tissue environments to facilitate healing and integration [28,29].”
Advances in the meta-analysis of heterogeneous clinical trials II: The quality effects model
Doi, S. A. R., Barendregt, J. J., Khan, S., Thalib, L., & Williams, G. M. (2015) · Contemporary Clinical Trials · doi:10.1016/j.cct.2015.05.010 · Cited by 227 · cited 1×
“Heterogeneity was assessed using I 2 , with values exceeding 75% indicating substantial unexplained variability [39].”
Hurley, E. T., Lim Fat, D., Moran, C. J., & Mullett, H. (2019) · The American Journal of Sports Medicine · doi:10.1177/0363546517751397 · Cited by 223
Strategic Design and Fabrication of Engineered Scaffolds for Articular Cartilage Repair
Izadifar, Z., Chen, X., & Kulyk, W. (2012) · Journal of Functional Biomaterials · doi:10.3390/jfb3040799 · Cited by 203 · cited 1×
“Engineered scaffolds are especially valuable in joint repair, as they offer structural support while promoting cellular proliferation and matrix deposition [30,31].”
Kim, Y. S., Sung, C. H., Chung, S. H., Kwak, S. J., & Koh, Y. G. (2017) · The American Journal of Sports Medicine · doi:10.1177/0363546517702863 · Cited by 176
Kim, K., Lee, M. C., Lee, J. H., Moon, Y., Lee, W.-S., Lee, H.-J., Hwang, S., In, Y., Shon, O., Bae, K., et al. (2023) · The American Journal of Sports Medicine · doi:10.1177/03635465231179223 · Cited by 160
Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020Preprint
Everts, P. A., Onishi, K., Jayaram, P., et al. (2020) · Preprints.org · doi:10.20944/preprints202010.0069.v1 · Cited by 157
Usuelli, F. G., Grassi, M., Maccario, C., Vigano’, M., Lanfranchi, L., Alfieri Montrasio, U., & de Girolamo, L. (2018) · Knee Surgery, Sports Traumatology, Arthroscopy · doi:10.1007/s00167-017-4479-9 · Cited by 156
Articular cartilage repair biomaterials: strategies and applications
Wang, M., Wu, Y., Li, G., Lin, Q., Zhang, W., Liu, H., & Su, J. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.100948 · Cited by 145
Advancements in hydrogel design for articular cartilage regeneration: A comprehensive review
Hashemi-Afzal, F., Fallahi, H., Bagheri, F., Collins, M. N., Eslaminejad, M. B., & Seitz, H. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.09.005 · Cited by 144 · cited 1×
“Biomimetic materials, including engineered scaffolds and autologous protein solutions, aim to mimic native tissue environments but require further refinement in delivery methods and long-term safety [129,130].”
Paget, L. D. A., Reurink, G., de Vos, R.-J., Weir, A., Moen, M. H., Bierma-Zeinstra, S. M. A., Stufkens, S. A. S., Kerkhoffs, G. M. M. J., Tol, J. L., PRIMA Study Group, et al. (2021) · JAMA · doi:10.1001/jama.2021.16602 · Cited by 138
Liebergall, M., Schroeder, J., Mosheiff, R., Gazit, Z., Yoram, Z., Rasooly, L., Daskal, A., Khoury, A., Weil, Y., & Beyth, S. (2013) · Molecular Therapy · doi:10.1038/mt.2013.109 · Cited by 134
Peptidic Biomaterials: From Self-Assembling to Regenerative Medicine
Pugliese, R., & Gelain, F. (2017) · Trends in Biotechnology · doi:10.1016/j.tibtech.2016.09.004 · Cited by 133 · cited 1×
“Ad-ditionally, growth factor-derived peptides have been explored as adjunct therapies to PRP, demonstrating enhanced wound healing and tendon regeneration [101,102].”
Kwong, C. A., Woodmass, J. M., Gusnowski, E. M., Bois, A. J., Leblanc, J., More, K. D., & Lo, I. K. Y. (2021) · Arthroscopy · doi:10.1016/j.arthro.2020.10.037 · Cited by 126 · cited 2×
“In tendon injuries and partial-thickness rotator cuff tears, PRP has shown potential for short-term improvement, yet the effects often diminish over time, highlighting the need for further refinement in preparation techniques to extend its benefits [15,16].”
Keene, D. J., Alsousou, J., Harrison, P., Hulley, P. A., Wagland, S., Parsons, S., Thompson, J., O’Connor, H., Schlüssel, M. M., Dutton, S., et al. (2019) · BMJ · doi:10.1136/bmj.l6132 · Cited by 120
Peptide-Based Functional Biomaterials for Soft-Tissue Repair
Hosoyama, K., Lazurko, C., Muñoz, M., McTiernan, C. D., & Alarcon, E. I. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00205 · Cited by 118
Platelet-rich Plasma in Orthopaedic Applications: Evidence-based Recommendations for Treatment
Hsu, W. K., Mishra, A. K., Rodeo, S. R., Fu, F. H., Terry, M. A., Randelli, P. S., Canale, T. S., & Kelly, F. B. (2013) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/jaaos-22-08-469 · Cited by 118 · cited 1×
“PRP therapy, which uses autologous platelets concentrated to deliver growth factors at injury sites, has been extensively studied for its potential to aid in soft tissue and bone repair [9–12].”
Bastos, R., Mathias, M., Andrade, R., Amaral, R. J. F. C., Schott, V., Balduino, A., Bastos, R., Miguel Oliveira, J., Reis, R. L., Rodeo, S., et al. (2020) · Knee Surgery, Sports Traumatology, Arthroscopy · doi:10.1007/s00167-019-05732-8 · Cited by 117
Czajka, A., Kania, E. M., Genovese, L., Corbo, A., Merone, G., Luci, C., & Sibilla, S. (2018) · Nutrition Research · doi:10.1016/j.nutres.2018.06.001 · Cited by 117
Reurink, G., Goudswaard, G. J., Moen, M. H., Weir, A., Verhaar, J. A. N., Bierma‐Zeinstra, S., Maas, M. M., & Tol, J. L. (2015) · British Journal of Sports Medicine · doi:10.1136/bjsports-2014-094250 · Cited by 115
Sadri, B., Hassanzadeh, M., Bagherifard, A., Mohammadi, J., Alikhani, M., Moeinabadi‐Bidgoli, K., Madani, H., Diaz‐Solano, D., Karimi, S., Mehrazmay, M., et al. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03359-8 · Cited by 115
Wei, P., & Bao, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010059 · Cited by 115
Kearney, R. S., Ji, C., Warwick, J., Parsons, N., Brown, J., Harrison, P., Young, J., Costa, M. L., Collaborators, A. T., Dasari, K., et al. (2021) · JAMA · doi:10.1001/jama.2021.6986 · Cited by 113
Everts, P. A., Lana, J. F., Alexander, R. W., Dallo, I., Kon, E., Ambach, M. A., van Zundert, A. A. J., & Podesta, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147914 · Cited by 108
Beheshtizadeh, N., Gharibshahian, M., Pazhouhnia, Z., Rostami, M., Zangi, A. R., Maleki, R., Azar, H. K., Zalouli, V., Rajavand, H., Farzin, A., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113431 · Cited by 103 · cited 1×
“Establishing rigorous guidelines, refining patient selection, and integrating emerging technologies such as AI-driven predictive modeling and biofabrication will be crucial [131–133].”
Kon, E., Engebretsen, L., Verdonk, P., Nehrer, S., & Filardo, G. (2018) · The American Journal of Sports Medicine · doi:10.1177/0363546517732734 · Cited by 98 · cited 1×
“Despite promising results, biomimetics are still in the experimental stages, and more extensive clinical trials are necessary to verify their long-term effectiveness and safety [33].”
Kon, E., Filardo, G., Brittberg, M., Busacca, M., Condello, V., Engebretsen, L., Marlovits, S., Niemeyer, P., Platzer, P., Posthumus, M., et al. (2017) · Knee Surgery Sports Traumatology Arthroscopy · doi:10.1007/s00167-017-4707-3 · Cited by 88
The Role of Extracellular Matrix (ECM) Adhesion Motifs in Functionalised Hydrogels
Morwood, A. J., El-Karim, I. A., Clarke, S. A., & Lundy, F. T. (2023) · Molecules · doi:10.3390/molecules28124616 · Cited by 85 · cited 1×
“These personalized scaffolds are designed to mimic native bone and cartilage structure, supporting cell adhesion, migration, and differentiation for improved regenerative outcomes [121].”
Autologous Platelet-Rich Plasma: A Revolution in Soft Tissue Sports Injury Management?
Mei-Dan, O., Lippi, G., Sánchez, M., Andia, I., & Maffulli, N. (2010) · The Physician and Sportsmedicine · doi:10.3810/psm.2010.12.1835 · Cited by 83 · cited 1×
“PRP’s efficacy in Achilles tendinopathy and knee osteoarthritis has yielded mixed results, with some trials reporting no significant benefit over placebo, underscoring the lack of standardization in PRP preparation [13,95,96].”
Enhanced recovery after surgery for major orthopedic surgery: a narrative review
Choi, Y. S., Kim, T. W., Chang, M. J., Kang, S.-B., & Chang, C. B. (2022) · Knee Surgery & Related Research · doi:10.1186/s43019-022-00137-3 · Cited by 83
Everts, P. A., Lana, J. F., Alexander, R. W., Dallo, I., Kon, E., Ambach, M. A., van Zundert, A., & Podesta, L. (2024) · doi:10.20944/preprints202405.1757.v1 · Cited by 83
Farr, J., Gomoll, A. H., Yanke, A. B., Strauss, E. J., Mowry, K. C., & ASA Study Group (2019) · The Journal of Knee Surgery · doi:10.1055/s-0039-1696672 · Cited by 81
Advancements and Challenges in Stem Cell Transplantation for Regenerative Medicine
Wei, L., Yan, W., Shah, W., Zhang, Z., Wang, M., Liu, B., Xue, Z., Cao, Y., Hou, X., Zhang, K., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35836 · Cited by 79 · cited 1×
“MSC-based therapies demonstrate superior potential in cartilage repair and osteoarthritis, yet high costs and regulatory barriers hinder clinical adoption [125,126].”
Liebig, B. E., Kisiday, J. D., Bahney, C. S., Ehrhart, N. P., & Goodrich, L. R. (2020) · Journal of Orthopaedic Research® · doi:10.1002/jor.24786 · Cited by 68
Advances and prospects in biomimetic multilayered scaffolds for articular cartilage regeneration
Fu, L., Yang, Z., Gao, C., Li, H., Yuan, Z., Wang, F., Sui, X., Liu, S., & Guo, Q. (2020) · Regenerative Biomaterials · doi:10.1093/rb/rbaa042 · Cited by 65 · cited 1×
“Biomimetic scaffolds have demonstrated cartilage-regenerating properties, acting as a structural support matrix that enhances cell proliferation and tissue repair [105].”
Pintore, A., Notarfrancesco, D., Zara, A., Oliviero, A., Migliorini, F., Oliva, F., & Maffulli, N. (2023) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-023-03841-2 · Cited by 65 · cited 1×
“Studies show that intra-articular MSC injections lead to statistically significant improvements in pain scores and functional outcomes, with greater efficacy observed in early-stage osteoarthritis [68].”
Jayaram, P., Mitchell, P., Shybut, T. B., Moseley, B., & Lee, B. (2023) · The American Journal of Sports Medicine · doi:10.1177/03635465231170394 · Cited by 65 · cited 1×
“Moreover, the growing interest in leukocyte-poor PRP (LP-PRP) versus leukocyte-rich PRP (LR-PRP) has led to investigations regarding their differing immunomodulatory properties and potential applications in specific injury types [110].”
Wang, Y., Lee, C.-L., Chen, Y.-J., Tien, Y.-C., Lin, S., Chen, C., Chou, P. P., & Huang, H. (2022) · Medicina · doi:10.3390/medicina58081028 · Cited by 60
Antimicrobial Peptides in the Battle against Orthopedic Implant-Related Infections: A Review
Costa, B., de Tejada, G. M., Gomes, P. A. C., Martins, M. C. L., & Costa, F. M. T. A. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111918 · Cited by 60
Hagino, H., Sugimoto, T., Tanaka, S., Sasaki, K., Sone, T., Nakamura, T., Soen, S., & Mori, S. (2021) · Osteoporosis International · doi:10.1007/s00198-021-05996-2 · Cited by 59
Advanced 3D-Printing Bioinks for Articular Cartilage Repair
Liang, Q., Ma, Y., Yao, X., & Wei, W. (2022) · International Journal of Bioprinting · doi:10.18063/ijb.v8i3.511 · Cited by 55 · cited 1×
“APS, derived from autologous blood, has shown sustained pain relief, and improved functional outcomes in knee osteoarthritis, positioning it as a potential alternative to corticosteroid injections [104].”
Zhou, J., Li, Q., Tian, Z., Yao, Q., & Zhang, M. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100870 · Cited by 53 · cited 1×
“…investigations into biomimetic coatings for orthopedic implants, particularly calcium phosphate-based nanostructured surfaces, suggest their potential to enhance osseointegration and improve implant integration; however, their clinical advantage continues to be a subject of ongoing research [120].”
Randelli, P. S., Cucchi, D., FOSSATI, C., et al. (2022) · The American Journal of Sports Medicine · doi:10.1177/03635465221083324 · Cited by 49
Hurley, E. T., Sherman, S. L., Stokes, D. J., Rodeo, S. A., Shapiro, S. A., Mautner, K., Buford, D. A., Dragoo, J. L., Mandelbaum, B. R., Zaslav, K. R., et al. (2024) · Arthroscopy · doi:10.1016/j.arthro.2023.08.020 · Cited by 49 · cited 2×
“The inconsistencies in PRP outcomes are often attributed to differences in platelet concentration, activation methods, and leukocyte content, making direct comparisons between studies difficult [108].”
Autologous Protein Solution Injections for the Treatment of Knee Osteoarthritis: 3-Year Results
Kon, E., Engebretsen, L., Verdonk, P., Nehrer, S., & Filardo, G. (2020) · The American Journal of Sports Medicine · doi:10.1177/0363546520944891 · Cited by 48 · cited 1×
“Meanwhile, autologous protein solutions, derived from the patient’s own blood, concentrate regenerative proteins and cytokines, providing an option for sustained pain relief and functional improvement [32].”
Kim, S. J., Yeo, S. M., Noh, S. J., Ha, C., Lee, H. S., Lee, H. S., & Kim, S. J. (2019) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-019-1406-4 · Cited by 48
The role of platelet-rich plasma in biomedicine: A comprehensive overview
Zhang, Z., Liu, P., Xue, X., Zhang, Z., Wang, L., Jiang, Y., Zhang, C., Zhou, H., Lv, S., Shen, W., et al. (2025) · iScience · doi:10.1016/j.isci.2024.111705 · Cited by 48 · cited 1×
“Additionally, heterogeneity in study methodologies-particularly in PRP preparation, MSC sourcing, and peptide dosing-poses a challenge in drawing definitive conclusions regarding treatment efficacy [122,123].”
Antimicrobial peptides for bone tissue engineering: Diversity, effects and applications
Hao, Z., Chen, R., Chai, C., Wang, Y., Chen, T., Li, H., Hu, Y., Feng, Q., & Li, J. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1030162 · Cited by 47 · cited 1×
“Ad-ditionally, growth factor-derived peptides have been explored as adjunct therapies to PRP, demonstrating enhanced wound healing and tendon regeneration [101,102].”
Gupta, A., Maffulli, N., Rodriguez, H. C., Lee, C. E., Levy, H. J., & El‐Amin, S. F. (2021) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-021-02300-0 · Cited by 44
Rossi, L. A., Gorodischer, T., Camino, P., Brandariz, R. N., Tanoira, I., Piuzzi, N. S., & Ranalletta, M. (2024) · The American Journal of Sports Medicine · doi:10.1177/03635465241239062 · Cited by 43
Ye, Z., Chen, H., Qiao, Y., Wu, C., Cho, E., Wu, X., Li, Z., Wu, J., Lu, S., Xie, G., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.10134 · Cited by 42
Wongjarupong, A., Pairuchvej, S., Laohapornsvan, P., et al. (2023) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-023-06429-3 · Cited by 40
Keene, D. J., Alsousou, J., Harrison, P., O’Connor, H., Wagland, S., Dutton, S., Hulley, P. A., Lamb, S. E., Willett, K. M., & on behalf of the PATH-2 Trial group (2022) · The Bone & Joint Journal · doi:10.1302/0301-620x.104b11.bjj-2022-0653.r1 · Cited by 40
Pers, Y., Soler, R., Vadalà, G., Ferreira, R., Duflos, C., Picot, M., Herman, F., Broussous, S., Sánchez, A., Noriega, D. C., et al. (2024) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2024-225771 · Cited by 40
Awad, M. E., Hussein, K. A., Helwa, I., Abdelsamid, M. F., Aguilar-Perez, A., Mohsen, I., Hunter, M., Hamrick, M. W., Isales, C. M., Elsalanty, M., et al. (2019) · Stem Cells International · doi:10.1155/2019/3826054 · Cited by 39 · cited 1×
“Some evidence suggests leukocyte-poor PRP may be superior for tendinopathy, whereas leukocyte-rich PRP may be more effective in ligament and cartilage repair [97].”
Kamble, P., Prabhu, R. M., Jogani, A., Mohanty, S. S., Panchal, S., & Dakhode, S. Y. (2022) · Clinics in Orthopedic Surgery · doi:10.4055/cios22128 · Cited by 35
Everts, P. A., Mazzola, T., Mautner, K., Randelli, P. S., & Podesta, L. (2022) · Biomedicines · doi:10.3390/biomedicines10112933 · Cited by 34 · cited 1×
“PRP provides short-term symptomatic relief, particularly in tendon and ligament injuries, but variability in preparation limits its long-term efficacy [124,125].”
Zdzieblik, D., Brame, J., Oesser, S., Gollhofer, A., & König, D. (2021) · Nutrients · doi:10.3390/nu13020523 · Cited by 34
Kleiderman, E., Boily, A., Hasilo, C., & Knoppers, B. M. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-1055-2 · Cited by 34 · cited 2×
“Moreover, self-assembling peptide hydrogels have been developed to provide a bioactive matrix that facilitates tissue repair, offering a promising solution for tendon and cartilage defects [122].”
Chen, X., Zheng, J., Yin, L., Li, Y., & Liu, H. (2024) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-024-04846-1 · Cited by 34 · cited 1×
“However, their clinical translation remains hindered by high treatment costs, ethical concerns, and regulatory barriers [111].”
D'Souza, R. S., Her, Y. F., Hussain, N., Karri, J. V., Schatman, M. E., Calodney, A. K., Lam, C. M., Buchheit, T., Boettcher, B. J., Chien, G. C. C., et al. (2024) · Journal of Pain Research · doi:10.2147/jpr.s480559 · Cited by 34
Mesenchymal Stromal Cells for Aging Cartilage Regeneration: A Review
Wu, K.-C., Chang, Y.-H., Ding, D.-C., & Lin, S.-Z. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312911 · Cited by 33 · cited 2×
“PRP provides short-term symptomatic relief, particularly in tendon and ligament injuries, but variability in preparation limits its long-term efficacy [124,125].”
Zhao, J., Liang, G., Han, Y., Yang, W., Xu, N., Luo, M., Pan, J., Liu, J., & Zeng, L.-F. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-061008 · Cited by 32 · cited 1×
“Some trials have explored combination therapies such as MSC + PRP, which have shown enhanced cartilage regeneration and faster fracture healing compared to either intervention alone [98].”
Mohammadivahedi, F., Sadeghifar, A., Farsinejad, A., Jambarsang, S., & Mirhosseini, H. (2024) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-024-04917-3 · Cited by 32
Vrouwe, J. P. M., Meulenberg, J. J. M., Klarenbeek, N. B., Navas-Cañete, A., Reijnierse, M., Ruiterkamp, G., Bevaart, L., Lamers, R. J., Kloppenburg, M., Nelissen, R. G. H. H., et al. (2021) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2021.09.013 · Cited by 29
Owida, H. A. (2022) · Advances in Orthopedics · doi:10.1155/2022/8670174 · Cited by 29 · cited 2×
“Some studies indicate that collagen-derived peptides may stimulate chondrocyte activity, potentially slowing cartilage degeneration in osteoarthritis patients, but further large-scale trials are required [103].”
Jamal, M. S., Hurley, E. T., Asad, H., Asad, A., & Taneja, T. (2022) · Journal of Clinical Orthopaedics and Trauma · doi:10.1016/j.jcot.2021.101759 · Cited by 28 · cited 1×
“PRP’s efficacy in Achilles tendinopathy and knee osteoarthritis has yielded mixed results, with some trials reporting no significant benefit over placebo, underscoring the lack of standardization in PRP preparation [13,95,96].”
Hurdles to uptake of mesenchymal stem cells and their progenitors in therapeutic products
Childs, P. G., Reid, S., Salmeron-Sanchez, M., & Dalby, M. J. (2020) · Biochemical Journal · doi:10.1042/bcj20190382 · Cited by 27 · cited 1×
“Studies suggest that antimicrobial peptides (AMPs) can be effectively incorporated into orthopedic implants to reduce post-surgical infections, yet their clinical effectiveness remains an area of ongoing investigation [115].”
Zarghami, V., Ghorbani, M., Bagheri, K. P., & Shokrgozar, M. A. (2021) · Journal of Materials Science: Materials in Medicine · doi:10.1007/s10856-021-06551-5 · Cited by 26 · cited 1×
“Peptide-based therapies, which encompass antimicrobial peptides and growth factors, are particularly appealing for their dual ability to combat infection and promote healing [23,24].”
Oliviero, F., Ramonda, R., Hoxha, A., et al. (2020) · Reumatismo · doi:10.4081/reumatismo.2020.1272 · Cited by 25
Huang, L., Zhang, S., Wu, J., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01670-7 · Cited by 24
Azadi, S., Yazdanpanah, M. A., Afshari, A., Alahdad, N., Chegeni, S., Angaji, A., Rezayat, S. M., & Tavakol, S. (2024) · Journal of Tissue Engineering · doi:10.1177/20417314241303818 · Cited by 24 · cited 1×
“Peptides integrated into bioactive scaffolds show potential for infection con-trol and tissue regeneration, yet clinical translation remains limited [127,128].”
Zou, G., Zheng, M., Chen, W., He, X. O., & Cang, D. (2020) · Journal of International Medical Research · doi:10.1177/0300060520903636 · Cited by 23
Piuzzi, N. S., Emara, A., Chahla, J., & Mandelbaum, B. R. (2020) · Current Reviews in Musculoskeletal Medicine · doi:10.1007/s12178-020-09647-7 · Cited by 21 · cited 1×
“Preclinical studies indicate that MSC-derived EVs may mediate cartilage repair and reduce inflammation, potentially offering a safer, standardized alternative to traditional MSC injections [114].”
Schneider, U., Kumar, A., Murrell, W., et al. (2021) · International Orthopaedics · doi:10.1007/s00264-020-04870-w · Cited by 21
Waluyo, Y., Budu, Bukhari, A., Adnan, E., Darjanti Haryadi, R., Idris, I., Hamid, F., Usman, A., Phetrus Johan, M., & Alfian Zainuddin, A. (2021) · Journal of Rehabilitation Medicine · doi:10.2340/16501977-2835 · Cited by 21 · cited 1×
“Some studies suggest that intra-articular dextrose prolotherapy may provide superior pain relief and cartilage protection compared to hyaluronic acid injections, though further research is needed to confirm long-term benefits [94].”
Yoshioka, T., Arai, N., Sugaya, H., Taniguchi, Y., Kanamori, A., Gosho, M., Okuno, K., Kikuchi, N., Hyodo, K., Aoto, K., et al. (2024) · The American Journal of Sports Medicine · doi:10.1177/03635465241263073 · Cited by 21
Pitsilos, C., Karachrysafi, S., Fragou, A., Gigis, I., Papadopoulos, P. P., & Chalidis, B. E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147957 · Cited by 21
Kuwaba, K., Kusubata, M., Taga, Y., Igarashi, H., Nakazato, K., & Mizuno, K. (2023) · Journal of the International Society of Sports Nutrition · doi:10.1080/15502783.2023.2206392 · Cited by 20
Morya, V. K., Shahid, H., Lang, J., Kwak, M. K., Park, S.-H., & Noh, K.-C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111846 · Cited by 20 · cited 1×
“Available data suggest that MSC-based treatments provide more durable long-term benefits in cartilage repair, whereas PRP offers a more accessible but shorter-lived alternative for pain relief [106,107].”
Platelet-rich plasma in orthopedics: Bridging innovation and clinical applications for bone repair
Zhu, L., Li, P., Qin, Y., et al. (2024) · Journal of orthopaedic surgery · doi:10.1177/10225536231224952 · Cited by 19
Antimicrobial Peptides in the Battle Against Orthopedic Implant-Related Infections – A ReviewPreprint
Costa, B., de Tejada, G. M., Gomes, P. A. C., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3873682 · Cited by 18
Chen, C., Chen, C., Chen, Y., et al. (2024) · Cell Transplantation · doi:10.1177/09636897231221882 · Cited by 17
Orozco, L., Soler, R., Arriaza, R., García, A. M., & Barrena, E. G. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05280-x · Cited by 17
Montesissa, M., Sassoni, E., Boi, M., Borciani, G., Boanini, E., & Graziani, G. (2024) · Nanomaterials · doi:10.3390/nano14161332 · Cited by 17 · cited 1×
“APS has demonstrated longer-lasting benefits than traditional steroid injections for osteoarthritis management, while biomimetic scaffolds have shown promise in cartilage repair and structural support for musculoskeletal injuries [119].”
Scalzone, A., Sanjurjo-Rodríguez, C., Berlinguer-Palmini, R., Dickinson, A. M., Jones, E., Wang, X.-N., & Crossland, R. E. (2024) · Bioengineering · doi:10.3390/bioengineering11040388 · Cited by 16 · cited 1×
“Recent advances in exosome therapy and MSC-derived extracellular vesicles (EVs) have shown promise as alternative regenerative strategies, delivering the therapeutic benefits of MSCs without the challenges of direct cell transplantation [113].”
Toosi, S. H., Naderi‐Meshkin, H., Moradi, A., Daliri, M., Moghimi, V., Majd, H. M., Sahebkar, A. H., Heirani‐Tabasi, A., & Behravan, J. (2023) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c00677 · Cited by 16
Tang, S., Wang, L., Zhang, Y., & Zhang, F. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.887454 · Cited by 15
Rodriguez, J. E., Williams, D. R., & Bürkner, P. (2023) · British Journal of Mathematical and Statistical Psychology · doi:10.1111/bmsp.12299 · Cited by 14 · cited 1×
“To evaluate differences in pain reduction across therapy types while accounting for between-study heterogeneity, a random-effects meta-regression analysis was conducted using the restricted maximum likelihood (REML) method [37,38].”
Hewavithana, P. B., Wettasinghe, M. C., Hettiarachchi, G., Ratnayaka, M., Suraweera, H. J., Wickramasinghe, N. D., & Kumarasiri, P. V. R. (2023) · Skeletal Radiology · doi:10.1007/s00256-023-04373-w · Cited by 14
Mashweu, A. R., & Azov, V. A. (2024) · Molecules · doi:10.3390/molecules29235654 · Cited by 14
Platelet-rich plasma treatment for talar cartilage repair: a systematic review and meta-analysis
Peng, J., Wang, Q., Xu, Y., & He, H. (2023) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-023-06466-y · Cited by 13 · cited 2×
“However, PRP’s therapeutic efficacy varies, largely due to inconsistent preparation methods and differing platelet concentrations, which can significantly influence treatment outcomes [13,14].”
Devasia, S., Joseph, J. T., Stephena, P. S., et al. (2024) · Cartilage · doi:10.1177/19476035231221211 · Cited by 12
Local and Systemic Peptide Therapies for Soft Tissue Regeneration: A Narrative Review
Cushman, C. J., Ibrahim, A. F., Smith, A. D., Hernandez, E. J., MacKay, B., & Zumwalt, M. (2024) · The Yale Journal of Biology and Medicine · doi:10.59249/tknm3388 · Cited by 12 · cited 1×
“However, optimal dosage and delivery methods for peptides remain under-researched, indicating the need for further study to fully determine their role in orthopedic interventions [27].”
Vieira, M. H. C., Schweich-Adami, L. D. C., Oliveira, R. J., et al. (2024) · Cell and Tissue Banking · doi:10.1007/s10561-024-10141-4 · Cited by 10
Xu, R., Li, J., Zhang, H., et al. (2024) · Medicine · doi:10.1097/md.0000000000039369 · Cited by 10
The Potential of Intra-Articular Therapies in Managing Knee Osteoarthritis: A Systematic Review
Pojala, C. V., Toma, S., Costache, C., Peter, T., Pojala, C. E., Roman, N. A., & Dima, L. (2024) · Clinics and Practice · doi:10.3390/clinpract14050157 · Cited by 10 · cited 2×
“PRP also appears to have limited benefit in certain conditions, such as Achilles tendinopathy and knee osteoarthritis, where trials have reported no significant improvement over placebo [109].”
Regenerative Medicine in Orthopaedic Surgery: Pioneering Advances and Their Applications
Islam, M. T., Bulut, D., & Sharabidze, Z. (2025) · EMJ Innovation · doi:10.33590/emjinnov/fgds3814 · Cited by 10 · cited 2×
“Despite the increasing number of studies on regenerative medicine in orthopedics, the field remains fragmented, with inconsistent findings across trials and a lack of standardization in therapy preparation and clinical application [2].”
Schulze, C., Schunck, M., Zdzieblik, D., & Oesser, S. (2024) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph21060687 · Cited by 10 · cited 1×
“Additionally, recent studies suggest that collagen-derived peptides may play a role in cartilage preservation by stimulating chondrocyte activity and extracellular matrix synthesis, providing a potential avenue for early-stage osteoarthritis management [84].”
Zampogna, B., Parisi, F. R., Ferrini, A., Zampoli, A., Papalia, G. F., Shanmugasundaram, S., & Papalia, R. (2024) · Journal of Clinical Orthopaedics and Trauma · doi:10.1016/j.jcot.2024.102804 · Cited by 10 · cited 1×
“Similarly, MSC-based therapies, particularly those utilizing MSCs derived from bone marrow, adipose tissue, or umbilical cord blood, offer substantial regenerative potential due to their ability to differentiate into various tissue types and modulate immune responses [17,18].”
Mashweu, A. R., & Azov, V. A. (2024) · doi:10.20944/preprints202410.2092.v1 · Cited by 10
Kruijntjens, D. S. M. G., Kjærsgaard‐Andersen, P., Revald, P., Leonhardt, J. S., Arts, J. J. C., & ten Broeke, R. H. M. (2018) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-018-0888-9 · Cited by 9
Platelet rich plasma and anterior cruciate ligament repair: A new frontier, or a short term adjunct
Gill, S. S., Cenci, G., Falcinelli, S., Marzano, F., Carriero, B., Filippi, N., & Pace, V. (2025) · World Journal of Orthopedics · doi:10.5312/wjo.v16.i1.100693 · Cited by 9
Annaniemi, J. A., Pere, J., & Giordano, S. A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm12010102 · Cited by 9
Editorial: Regenerative biologics for musculoskeletal injuries
Gupta, A., Potty, A. G. R., & Maffulli, N. (2024) · Frontiers in Pain Research · doi:10.3389/fpain.2024.1400548 · Cited by 8
Pennone, V., Rosini, E., Mascheroni, E., Gianola, S., Castellini, G., Bargeri, S., & Lovati, A. B. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1370826 · Cited by 8 · cited 1×
“Antimicrobial peptides (AMPs) have been incorporated into biomaterials for orthopedic implants, showing reduced bacterial colonization and lower post-surgical infection rates [100].”
Toàn, D. Đ., Bình, N. T., Dung, T. T., Thùy, L. Q., Hoa, N. D., Long, N. H., & Tung, P. S. (2019) · Journal of Back and Musculoskeletal Rehabilitation · doi:10.3233/bmr-191665 · Cited by 7
Regenerative Medicine in Orthopedic Surgery: Expanding Our Toolbox
Ibrahim, A., Gupton, M., & Schroeder, F. (2024) · Cureus · doi:10.7759/cureus.68487 · Cited by 7
Widodo, W., Dilogo, I. H., Kamal, A. F., Antarianto, R. D., Wuyung, P. E., Siregar, N. C., Octaviana, F., Kekalih, A., Suroto, H., Latief, W., et al. (2024) · European Journal of Orthopaedic Surgery & Traumatology · doi:10.1007/s00590-024-04110-6 · Cited by 7
Chaverri, D., Gallardo-Villares, S., Pinto, J. A., Rodrı́guez, L., Codinach, M., García‐López, J., Querol, S., Coll, R., Vives, J., & Granell-Escobar, F. (2024) · Injury · doi:10.1016/j.injury.2024.111596 · Cited by 6
Eckstein, F., Maschek, S., Wirth, W., et al. (2024) · Osteoarthritis and Cartilage Open · doi:10.1016/j.ocarto.2024.100513 · Cited by 4
Effectiveness of Platelet-Rich Plasma in the Treatment of Moderate Knee Osteoarthritis
Munde, S., Jha, V., Malik, J., & Malik, J. S. (2017) · Annals of International medical and Dental Research · doi:10.21276/aimdr.2017.3.4.or9 · Cited by 3
Recent Trends and Scope of Nanotechnology in Orthopaedic Surgery: A Narrative Review
Pol, S. H. S. (2024) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2024/69980.19480 · Cited by 2 · cited 1×
“However, clinical evidence remains limited, and some trials have reported only marginal benefits over standard treatment protocols [118].”
Research works printed but not linked: 1
- Chaudhary, 2024, Emerging trends in PRP and MSC-based therapies: A review of clinical efficacy and limitations, Int. J. Musculoskelet. Med., 12, 85
Cited by
Aithal, A. (2025) · Poornaprajna International Journal of Basic & Applied Sciences (PIJBAS) · doi:10.64818/pijbas.3107.8478.0017 · Cited by 6
Cavallo, C., Desando, G., D’Alessandro, M., Grigolo, B., & Roseti, L. (2025) · Gels · doi:10.3390/gels11070551 · Cited by 8
“Long-term clinical results are still needed to support the use of those strategies [108].”
Pham, G. M.-T. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14196959 · Cited by 13
“Hybrid constructs combining multiple strategies such as scaffold + PRP + exosome or scaffold + BMAC + peptide are also being tested to optimize the healing microenvironment [8,26].”
Kim, S.-H., Lee, U., Yoon, Y., et al. (2026) · Bioengineering · doi:10.3390/bioengineering13040418 · Cited by 3
“Regenerative approaches—including prolotherapy, platelet‑rich plasma (PRP), and cell‑based therapies— aim to stimulate collagen remodeling and structural reinforcement at sites of ligamen‑ tous or enthesis‑level pathology [15–18].”
Platelet rich plasma applications in orthopedics: A review of recent advances
Rathod, A. P., Rathod, Y., Baitule, R. W., Pundkar, G. N., & Saodekar, H. (2025) · World Journal of Orthopedics · doi:10.5312/wjo.v16.i12.110377 · Cited by 5
Metadata
- Authors
- Goulian, A. J., Goldstein, B., & Saad, M. A.
- Affiliations
- California Northstate University (US)
- Department of Orthopaedic Surgery, University of California, Sacramento, CA 95817, USA
- Corresponding author
- Saad, Maarouf A.
- ORCID
- Goulian, Andrew J.
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2025-03-18
- Volume
- 14
- Issue
- 6
- Pages
- 2061
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC11943164
- OpenAlex
- W4408551393
- Cited by
- 25
- References
- 136
- Citations by year
- 2026: 14 · 2025: 11
- FWCI
- 5.19
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Dentistry › Periodontics › Periodontal Regeneration and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Tendon Structure and Treatment
- Keywords
- regenerative therapy, orthopedics, platelet-rich plasma, mesenchymal stem cells, peptide therapy, biomimetic materials, analgesia, functional recovery, cartilage regeneration, osteoarthritis, engineered scaffolds, wound healing, infection control, tendon repair
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.